CpG Immunotherapy in Chenopodium album sensitized mice: The comparison of IFN-gamma, IL-10 and IgE responses in intranasal and subcutaneous administrations

被引：5

作者：

Mousavi T. ^{[1
]}

Tajik N. ^{[1
]}

Moradi M. ^{[2
]}

Radjabzadeh M.F. ^{[1
]}

机构：

[1] Department of Immunology, Iran University of medical sciences, Tehran

[2] Department of Social Medicine, Iran university of Medical Sciences, Tehran

来源：

Clinical and Molecular Allergy | / 6卷 / 1期

关键词：

Treated Mouse; Allergenic Extract; Chenopodium Album; Splenocytes Culture; Induce Asthma;

D O I：

10.1186/1476-7961-6-10

中图分类号：

学科分类号：

摘要：

Background: Mucosal-based immunotherapy has been already used as an alternative form of allergen delivery. In asthma, the poor success rate of immune modulation could be a consequence of inadequate immune modulation in the airways. Previously, we have found that subcutaneous (S.C) co-administration of a homemade allergenic extract from Chenopodium album (Ch.a) pollen and Guanine-Cytosine containing deoxynucleotides (CpG-ODNs) is effective to prevent the inflammatory responses in mouse. In this study we used CpG/Ch.a for immunotherapy of Ch.a-induced asthma and compared the intranasal (I.N) and S.C routes of administration concerning IFN-γ, IL-10 and total IgE responses. Methods: Ch.a sensitized mice were treated intranasaly or subcutaneously using CpG and Ch.a. extract. IFN-γ, IL-10 and total IgE were measured in supernatant culture of splenocytes and bronchoalveolor lavage (BAL) fluids by ELISA. Student's t test was used in the analysis of the results obtained from the test and control mice. Results: We found that I.N administration of CpG/Ch.a in sensitized mice significantly increased the production of systemic and mucosal IFN-γ and IL-10 compared to phosphate buffered saline (PBS), Ch.a alone and control ODNs treated sensitized mice (P ≤ 0.001). On the other hand, S.C. route induced the systemic and mucosal IFN-γ in the lower levels than in I.N one, and failed to increase systemic IL-10 induction (P = 0.06). Total serum IgE in CpG/Ch.a treated mice in both routes showed significant decreases compared to three control groups (P ≤ 0.01). The amounts of IgE in BAL fluids were not measurable in all groups. Conclusion: According to the results of this experiment we concluded that immunotherapy via the I.N co-administration of CpG/Ch.a in comparison with S.C route is more effective to stimulate the mucosal and regulatory responses in Ch.a induced asthma. © 2008 Mousavi et al; licensee BioMed Central Ltd.

引用

共 25 条

[1]

Doina M., Racilam J.N., Kline M., Perspectives in asthma: Molecular use of microbial products in asthma prevention and treatment, J Allergy Clin Immunol, 116, 6, pp. 1202-1206, (2005)

[2]

Jain V.V., Kline J.N., CpG DNA: Immunomodulation and remodeling of the asthmatic airway, Expert Opin Biol Ther, 4, 9, pp. 1533-1540, (2004)

[3]

Ikeda R.K., Nayar J., Cho J.Y., Miller M., Rodriguez M., Rosa D.S., Resolution of airway inflammation following ovalbumin inhalation. Comparison of ISS DNA and corticosteroids, Am J Respir Cell Mol Biol, 28, pp. 139-142, (2003)

[4]

Krieg A.M., CpG motifs in bacterial DNA and their immune effects, Annu Rev Immunol, 20, pp. 709-760, (2002)

[5]

Liu N., Ohnishi N., Ni L., Akira S., Bacon K.B., CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells, Nat Immunol, 4, pp. 687-693, (2003)

[6]

Linghua Z., Xingshan T., Fengzhen Z., In vivo oral administration effects of various Oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to psodorabied attenuated virus vaccine in newborn piglets, Vaccine, 26, 2, pp. 224-233, (2008)

[7]

Klinman D.M., Therapeutic applications of CpG-containing Oligodeoxynucleotides, Antisense Nucleic Acid Drug Dev, 8, 2, pp. 181-184, (1998)

[8]

Hussain I., Jain V.V., Kitagaki K., Businga T.R., O'Shaughnessy P., Kline J.N., Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides, J Laryngoscope, 112, 10, pp. 1819-1826, (2002)

[9]

Broide D.H., Stachnick G., Castaneda D., Nayar J., Miller M., Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma, J Clin Immunol, 21, pp. 175-182, (2001)

[10]

Jain V.V., Businga T.R., Kitagaki K., George C.L., O'Shaughnessy P.T., Kline J.N., Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure, Am J Physiol Lung Cell Mol Physiol, 285, 5, (2003)

← 1 2 3 →